Picture of Nuwellis logo

NUWE Nuwellis Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Annual cashflow statement for Nuwellis, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

R2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-19.6-14.5-20.2-11.2-17.5
Depreciation
Non-Cash Items1.33-1.593.331.576.76
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.1040.598-1.42-0.305-0.253
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Payable / Accrued Expenses
Net Change in Other Assets & Liabilities
Cash from Operating Activities-17.8-15.1-17.9-9.59-10.8
Capital Expenditures-0.219-0.122-0.248-0.06-0.09
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-15.514.80.5780
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-15.714.70.33-0.06-0.09
Financing Cash Flow Items4
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities27.99.423.68116.94
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-5.78.99-13.91.29-3.9